Dopamine d2 Receptor antibody (3rd Cytoplasmic Domain)
Quick Overview for Dopamine d2 Receptor antibody (3rd Cytoplasmic Domain) (ABIN1733733)
Target
See all Dopamine d2 Receptor (DRD2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- 3rd Cytoplasmic Domain
-
Specificity
- Reacts with human DRD2
-
Cross-Reactivity (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins, except ZNF57 (42 % ).
-
Purification
- Antigen affinity purified
-
Immunogen
- Synthetic 19 amino acid peptide from 3rd cytoplasmic domain of human DRD2. Percent identity with other species by BLAST analysis: Human, Chimpanzee, Gorilla, Marmoset (100%), Gibbon, Monkey, Rabbit (95%), Dog, Bovine, Panda, Horse, Pig (89%), Mouse, Rat, Ferret, Bat, Hamster, Elephant (84%)
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Working dilution: IHC - P (3 μg/mL - 4
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-80 °C
-
Storage Comment
- Long term: -70°C, Short term: +4°C
-
-
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
-
Alternative Name
- Dopamine D2 Receptor
-
Pathways
- Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
Target
-